https://www.healthcarejournaloregon.com/article/911404232-erdem-health-group-enters-t-rkiye-s-turquality-program Healthcare Journal of Oregon en PressRelease 2026-05-08T15:00:00+00:00 Erdem Health Group Enters Türkiye’s TURQUALITY Program https://ml-eu.globenewswire.com/media/6d9ebfda-b492-4767-8803-0c83321cdd01/medium/cakmak-erdem-hospital.jpg https://www.healthcarejournaloregon.com/article/911404291-cytokinetics-announces-closing-of-public-offering-of-common-stock-and-full-exercise-of-the-underwriters-option-to-purchase-additional-shares-for Healthcare Journal of Oregon en PressRelease 2026-05-08T14:51:36+00:00 Cytokinetics Announces Closing of Public Offering of Common Stock and Full Exercise of the Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $805 Million https://ml.globenewswire.com/media/52e2be9f-e9e3-43af-a747-123fdcac4253/small/cytokinetics-png.png https://www.healthcarejournaloregon.com/article/911386290-inspire-named-best-patient-experience-platform-in-10th-annual-medtech-breakthrough-awards-program Healthcare Journal of Oregon en PressRelease 2026-05-08T14:10:00+00:00 Inspire Named “Best Patient Experience Platform” in 10th Annual MedTech Breakthrough Awards Program https://ml.globenewswire.com/media/OWVkODQ2MTktZDk0YS00M2Q0LWJlYmItYTIyYTRjMTgxZDUzLTUwMDEyOTE4NC0yMDI2LTA1LTA4LWVu/tiny/Inspire.png https://www.healthcarejournaloregon.com/article/911386518-ai-technology-transforms-cannabis-industry-as-leading-operators-drive-adoption-to-enhance-yields-and-compliance Healthcare Journal of Oregon en PressRelease 2026-05-08T13:52:16+00:00 AI Technology Transforms Cannabis Industry as Leading Operators Drive Adoption to Enhance Yields and Compliance https://ml.globenewswire.com/media/d0c282b6-d496-45a8-a941-33fa5c3e824c/small/bcc-logo-1200-630-png.png https://www.healthcarejournaloregon.com/article/911386301-merit-medical-to-participate-in-the-bank-of-america-healthcare-conference Healthcare Journal of Oregon en PressRelease 2026-05-08T13:25:00+00:00 Merit Medical to Participate in the Bank of America Healthcare Conference https://ml.globenewswire.com/media/19958d8f-47a4-44f3-a780-247335a68768/small/merit-medical-systems-inc-logo.jpg https://www.healthcarejournaloregon.com/article/911386310-envue-medical-adds-to-intellectual-property-portfolio-by-securing-uspto-notice-of-allowance-for-ultrasound-enhanced-cannabinoid-drug-delivery Healthcare Journal of Oregon en PressRelease 2026-05-08T13:15:00+00:00 ENvue Medical Adds to Intellectual Property Portfolio by Securing USPTO Notice of Allowance for Ultrasound-Enhanced Cannabinoid Drug Delivery Technology https://ml.globenewswire.com/media/e0a97028-a7c3-4dd6-a13f-a55e43617883/small/logo-small-722-jpg.jpg https://www.healthcarejournaloregon.com/article/911370850-alpha-tau-to-host-conference-call-to-discuss-interim-results-from-first-three-patients-treated-for-recurrent-glioblastoma Healthcare Journal of Oregon en PressRelease 2026-05-08T13:10:00+00:00 Alpha Tau to Host Conference Call to Discuss Interim Results from First Three Patients Treated for Recurrent Glioblastoma https://ml.globenewswire.com/media/a9de6f03-a487-4934-98e9-d25cdb4c8bed/small/atm-logo-jpg.jpg https://www.healthcarejournaloregon.com/article/911370178-philips-shareholders-approve-all-proposals-at-the-agm-2026 Healthcare Journal of Oregon en PressRelease 2026-05-08T13:01:04+00:00 Philips shareholders approve all proposals at the AGM 2026 https://ml-eu.globenewswire.com/media/e5826782-01bc-45e7-b448-9ca1eae0125e/small/philips-logo-logotype-emblem-700x128-png.png https://www.healthcarejournaloregon.com/article/911370587-bioage-labs-reports-first-quarter-2026-financial-results-and-provides-business-updates Healthcare Journal of Oregon en PressRelease 2026-05-08T13:00:00+00:00 BioAge Labs Reports First Quarter 2026 Financial Results and Provides Business Updates https://ml.globenewswire.com/media/d6df9eb5-87f7-4e2e-b503-8a7d8651428e/small/bioage-dark-logo-white-bg-500x500-png.png https://www.healthcarejournaloregon.com/article/911370826-alpha-tau-completes-patient-enrollment-in-its-u-s-pivotal-skin-cancer-study-advancing-towards-goal-of-fda-approval-of-alpha-dart-to-treat-recurrent Healthcare Journal of Oregon en PressRelease 2026-05-08T13:00:00+00:00 Alpha Tau Completes Patient Enrollment in its U.S. Pivotal Skin Cancer Study, Advancing Towards Goal of FDA Approval of Alpha DaRT® to Treat Recurrent Cutaneous Squamous Cell Carcinoma https://ml.globenewswire.com/media/a9de6f03-a487-4934-98e9-d25cdb4c8bed/small/atm-logo-jpg.jpg https://www.healthcarejournaloregon.com/article/911370911-j-star-holding-signs-mou-with-white-group-to-advance-financing-for-texas-solid-state-battery-facility Healthcare Journal of Oregon en PressRelease 2026-05-08T13:00:00+00:00 J-Star Holding Signs MOU with White Group to Advance Financing for Texas Solid-State Battery Facility https://ml.globenewswire.com/media/1a4c6faf-93be-4d28-a35f-1df9c4f0404e/small/j-star-logo-blue-transparent-png.png https://www.healthcarejournaloregon.com/article/911370159-allarity-therapeutics-ceo-to-present-at-precision-medicine-forum-europe-2026-in-stockholm Healthcare Journal of Oregon en PressRelease 2026-05-08T12:45:00+00:00 Allarity Therapeutics CEO to Present at Precision Medicine Forum Europe 2026 in Stockholm https://ml-eu.globenewswire.com/media/fd1e4c64-f0cf-40e0-a0c9-0be0d6dce544/small/allarity-full-color-rgb-2023jun07-png.png https://www.healthcarejournaloregon.com/article/911370672-moleculin-biotech-secures-strategic-additional-patent-strengthening-global-positioning-of-annamycin Healthcare Journal of Oregon en PressRelease 2026-05-08T12:45:00+00:00 Moleculin Biotech Secures Strategic Additional Patent, Strengthening Global Positioning of Annamycin https://ml.globenewswire.com/media/7fa09722-2ef8-49fc-bc24-6b150093f8ba/small/mbrx-logo-png.png https://www.healthcarejournaloregon.com/article/911371106-aim-immunotech-inc-announces-exercise-of-warrants-for-approx-4-2-million-in-gross-proceeds Healthcare Journal of Oregon en PressRelease 2026-05-08T12:40:00+00:00 AIM ImmunoTech, Inc. Announces Exercise of Warrants for Approx. $4.2 Million in Gross Proceeds https://ml.globenewswire.com/media/8e85b83b-047f-4f99-9c51-1aa232ffe9bb/small/aimlogo-jpg.jpg https://www.healthcarejournaloregon.com/article/911370349-aclaris-therapeutics-to-participate-in-the-2026-bank-of-america-healthcare-conference Healthcare Journal of Oregon en PressRelease 2026-05-08T12:30:00+00:00 Aclaris Therapeutics to Participate in the 2026 Bank of America Healthcare Conference https://ml.globenewswire.com/media/de2bcb21-de59-4226-bc8b-b1b747461f51/small/aclaris-logo-clr-jpg.jpg https://www.healthcarejournaloregon.com/article/911370612-prenetics-to-report-q1-2026-financial-results-on-may-14-2026-and-host-earnings-conference-call Healthcare Journal of Oregon en PressRelease 2026-05-08T12:30:00+00:00 Prenetics to Report Q1 2026 Financial Results on May 14, 2026 and Host Earnings Conference Call https://ml.globenewswire.com/media/106dbe1a-a6e1-49d9-97a2-c5609258bdc7/small/pre-logo-2026-png.png https://www.healthcarejournaloregon.com/article/911370712-cg-oncology-reports-first-quarter-2026-financial-results-and-provides-business-updates Healthcare Journal of Oregon en PressRelease 2026-05-08T12:30:00+00:00 CG Oncology Reports First Quarter 2026 Financial Results and Provides Business Updates https://ml.globenewswire.com/media/9e1cbdea-928e-4ea4-b4cd-33cdc36c6b2f/small/cgoncology-cover-jpg.jpg https://www.healthcarejournaloregon.com/article/911370964-inflarx-announces-closing-of-150-million-underwritten-offering-of-ordinary-shares Healthcare Journal of Oregon en PressRelease 2026-05-08T12:15:00+00:00 InflaRx Announces Closing of $150 Million Underwritten Offering of Ordinary Shares https://ml.globenewswire.com/media/e017df5c-9a9b-4f4f-9a94-6c2eeb0400bc/small/inflarx-logo-png.png https://www.healthcarejournaloregon.com/article/911370316-mimedx-announces-launch-of-g4derm-plus Healthcare Journal of Oregon en PressRelease 2026-05-08T12:00:00+00:00 MIMEDX Announces Launch of G4Derm® Plus https://ml.globenewswire.com/media/2a60ab36-4917-479c-b53a-4f2113ca347d/small/mimedx-png.png https://www.healthcarejournaloregon.com/article/911370604-humacyte-to-announce-2026-first-quarter-financial-results-and-provide-business-update-on-may-13-2026 Healthcare Journal of Oregon en PressRelease 2026-05-08T12:00:00+00:00 Humacyte To Announce 2026 First Quarter Financial Results and Provide Business Update on May 13, 2026 https://ml.globenewswire.com/media/e81aff26-ead8-404d-aebb-159b45c3e7b1/small/huma-logo-png.png https://www.healthcarejournaloregon.com/article/911370607-alx-oncology-reports-first-quarter-2026-financial-results-and-provides-corporate-update Healthcare Journal of Oregon en PressRelease 2026-05-08T12:00:00+00:00 ALX Oncology Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/0a1b4459-3df3-4c9f-ba29-ace8d7ad1b9a/small/alx-01-stacked-white-png.png https://www.healthcarejournaloregon.com/article/911370619-integra-lifesciences-to-present-at-the-bofa-securities-2026-health-care-conference Healthcare Journal of Oregon en PressRelease 2026-05-08T12:00:00+00:00 Integra LifeSciences to Present at the BofA Securities 2026 Health Care Conference https://ml.globenewswire.com/media/80d27f1a-2d8e-44f2-92e9-57e14db38652/small/integra-promotional-logos-integra-logo-full-color-process-1.png https://www.healthcarejournaloregon.com/article/911370636-pacira-biosciences-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Healthcare Journal of Oregon en PressRelease 2026-05-08T12:00:00+00:00 Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/3e502c92-e576-46b6-b602-a177ab0f5044/small/pacira-biosciences-tm-logo-rgb-v2025-300dpi-adj-png.png https://www.healthcarejournaloregon.com/article/911370805-biocardia-and-fda-align-on-helix-transendocardial-delivery-catheter-clearance-pathways Healthcare Journal of Oregon en PressRelease 2026-05-08T12:00:00+00:00 BioCardia and FDA Align on Helix Transendocardial Delivery Catheter Clearance Pathways https://ml.globenewswire.com/media/4641bb53-4913-4654-a337-79383a5c7ab9/small/biocardia-final-logo-2016-jpeg-jpg.jpg https://www.healthcarejournaloregon.com/article/911370907-alamar-biosciences-reports-first-quarter-2026-financial-results Healthcare Journal of Oregon en PressRelease 2026-05-08T12:00:00+00:00 Alamar Biosciences Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/9394cf1d-76c7-4cf9-8ed3-cafcc57c9a84/small/alamardroplogo-4c-png.png https://www.healthcarejournaloregon.com/article/911355251-plus-therapeutics-announces-oral-presentation-highlighting-reyobiq-clinical-and-translational-data-demonstrating-favorable-safety-survival-and Healthcare Journal of Oregon en PressRelease 2026-05-08T11:30:00+00:00 Plus Therapeutics Announces Oral Presentation Highlighting REYOBIQ™ Clinical and Translational Data Demonstrating Favorable Safety, Survival, and Emerging Immunomodulation in Leptomeningeal Metastases https://ml.globenewswire.com/media/92d7aa70-e37d-4870-bccf-d83b68ba5612/small/plus-logo-png.png https://www.healthcarejournaloregon.com/article/911355675-avicanna-announces-results-of-annual-general-and-special-meeting Healthcare Journal of Oregon en PressRelease 2026-05-08T11:30:00+00:00 Avicanna Announces Results of Annual General and Special Meeting https://ml.globenewswire.com/media/c9abc2f4-efdc-40f6-921d-a5da048eda46/small/avicanna-logo-colour-withtm-01-png.png https://www.healthcarejournaloregon.com/article/911355689-traws-pharma-to-advance-potential-clinical-candidates-for-the-treatment-of-hantavirus-infections Healthcare Journal of Oregon en PressRelease 2026-05-08T11:30:00+00:00 Traws Pharma to Advance Potential Clinical Candidates for the Treatment of Hantavirus Infections https://ml.globenewswire.com/media/1eb1780a-724e-4555-ab4d-455e27d18544/small/traws-pharma-blue-png.png https://www.healthcarejournaloregon.com/article/911355706-spectral-medical-announces-first-quarter-2026-financial-results-and-provides-corporate-update Healthcare Journal of Oregon en PressRelease 2026-05-08T11:30:00+00:00 Spectral Medical Announces First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/9516c02b-7f3b-41c0-bac1-a037af9a3240/small/new-spectral-logo-rgb-jpg.jpg https://www.healthcarejournaloregon.com/article/911355617-treace-medical-concepts-reports-first-quarter-2026-financial-results Healthcare Journal of Oregon en PressRelease 2026-05-08T11:05:00+00:00 Treace Medical Concepts Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/e6af4ccc-19b1-4fe0-948f-436f2b9d2ea5/small/treace-color-jpg.jpg https://www.healthcarejournaloregon.com/article/911355088-oxb-to-exhibit-and-present-at-the-30th-annual-meeting-of-the-american-society-of-cell-and-gene-therapy-asgct Healthcare Journal of Oregon en PressRelease 2026-05-08T11:00:00+00:00 OXB to exhibit and present at the 30th Annual Meeting of the American Society of Cell and Gene Therapy (ASGCT) https://ml-eu.globenewswire.com/media/3e905c0a-b28c-4981-ac57-745647779ad9/small/oxb-new-logo-png.png https://www.healthcarejournaloregon.com/article/911355200-le-consortium-international-de-recherche-sur-le-cancer-de-l-ovaire-annonce-une-nouvelle-bourse-pour-des-recherches-propuls-es-par-l-ia-visant-faire Healthcare Journal of Oregon en PressRelease 2026-05-08T11:00:00+00:00 Le Consortium international de recherche sur le cancer de l’ovaire annonce une nouvelle bourse pour des recherches propulsées par l’IA, visant à faire progresser les découvertes fondées sur les données https://ml.globenewswire.com/media/6d2e71b6-7ea9-4218-b59d-c718b24d7382/small/occ-logo-fr-clr-rgb-png.png https://www.healthcarejournaloregon.com/article/911355203-global-ovarian-cancer-research-consortium-announces-next-ai-accelerator-grant-to-advance-data-driven-discovery Healthcare Journal of Oregon en PressRelease 2026-05-08T11:00:00+00:00 Global Ovarian Cancer Research Consortium Announces Next AI Accelerator Grant to Advance Data-Driven Discovery https://ml.globenewswire.com/media/de07035a-bbf6-48bd-b4ea-ec41c0d06771/small/occ-logo-en-clr-rgb-1-png.png https://www.healthcarejournaloregon.com/article/911355434-lensar-reports-first-quarter-2026-results-and-provides-business-update Healthcare Journal of Oregon en PressRelease 2026-05-08T11:00:00+00:00 LENSAR® Reports First Quarter 2026 Results and Provides Business Update https://ml.globenewswire.com/media/4768eddf-0f87-4479-87f6-6b81f8ff392a/small/lensar-4color-jpg.jpg https://www.healthcarejournaloregon.com/article/911355605-boundless-bio-reports-first-quarter-2026-financial-results-and-business-highlights Healthcare Journal of Oregon en PressRelease 2026-05-08T11:00:00+00:00 Boundless Bio Reports First Quarter 2026 Financial Results and Business Highlights https://ml.globenewswire.com/media/3b8ff619-e7af-4c58-a7f2-de0c4019068d/small/boundlessbiologo-jpg.jpg https://www.healthcarejournaloregon.com/article/911355613-regeneron-named-to-dow-jones-best-in-class-world-index-for-global-responsibility-leadership-for-seven-consecutive-years Healthcare Journal of Oregon en PressRelease 2026-05-08T11:00:00+00:00 Regeneron Named to Dow Jones Best-in-Class World Index for Global Responsibility Leadership for Seven Consecutive Years https://ml.globenewswire.com/media/add5ebc7-88c9-49dc-8834-abbb07c622d1/small/regeneron-logo-jpg.jpg https://www.healthcarejournaloregon.com/article/911355644-hyperion-defi-announces-closing-of-public-offering-of-common-stock Healthcare Journal of Oregon en PressRelease 2026-05-08T11:00:00+00:00 Hyperion DeFi Announces Closing of Public Offering of Common Stock https://ml.globenewswire.com/media/2b21f207-e46f-4ad9-a6be-573e0bdc6c4c/small/hyperion-defi-single-logo-jpg.jpg https://www.healthcarejournaloregon.com/article/911355660-tvardi-therapeutics-announces-first-quarter-2026-results-and-provides-business-update Healthcare Journal of Oregon en PressRelease 2026-05-08T11:00:00+00:00 Tvardi Therapeutics Announces First Quarter 2026 Results and Provides Business Update https://ml.globenewswire.com/media/65859e40-e7db-474e-b604-78033b160f6b/small/tvardi-therapeutics-logo-1200-jpg.jpg https://www.healthcarejournaloregon.com/article/911355697-maplight-therapeutics-to-participate-in-upcoming-investor-conferences Healthcare Journal of Oregon en PressRelease 2026-05-08T11:00:00+00:00 MapLight Therapeutics to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/173b471e-5a67-4f12-84f2-06f4980ebd76/small/maplight-logo-horizontal-web-color-png.png https://www.healthcarejournaloregon.com/article/911355719-artiva-biotherapeutics-announces-pricing-of-300-million-underwritten-offering-of-common-stock-and-pre-funded-warrants Healthcare Journal of Oregon en PressRelease 2026-05-08T10:52:31+00:00 Artiva Biotherapeutics Announces Pricing of $300 Million Underwritten Offering of Common Stock and Pre-Funded Warrants https://ml.globenewswire.com/media/0392544b-ecff-4590-9eed-59c934e1ba4d/small/artiva-biotherapeutics-logo-jpg.jpg https://www.healthcarejournaloregon.com/article/911355628-ani-pharmaceuticals-reports-first-quarter-2026-financial-results-and-raises-2026-financial-guidance Healthcare Journal of Oregon en PressRelease 2026-05-08T10:50:00+00:00 ANI Pharmaceuticals Reports First Quarter 2026 Financial Results and Raises 2026 Financial Guidance https://ml.globenewswire.com/media/24d1d851-9075-4d6e-b22c-0c23a5ef0b36/small/ani-logo-png.png https://www.healthcarejournaloregon.com/article/911340646-artiva-biotherapeutics-reports-first-quarter-2026-financial-results-and-recent-business-highlights Healthcare Journal of Oregon en PressRelease 2026-05-08T10:31:00+00:00 Artiva Biotherapeutics Reports First Quarter 2026 Financial Results and Recent Business Highlights https://ml.globenewswire.com/media/0392544b-ecff-4590-9eed-59c934e1ba4d/small/artiva-biotherapeutics-logo-jpg.jpg https://www.healthcarejournaloregon.com/article/911340634-knight-therapeutics-announces-regulatory-approval-of-tavalisse-in-brazil Healthcare Journal of Oregon en PressRelease 2026-05-08T10:30:00+00:00 Knight Therapeutics Announces Regulatory Approval of TAVALISSE® in Brazil https://ml.globenewswire.com/media/e9457092-692d-4bfd-b361-9799ee8d73cd/small/logo-knight-256x256px-jpg.jpg https://www.healthcarejournaloregon.com/article/911340639-th-rapeutique-knight-annonce-l-approbation-r-glementaire-de-tavalisse-au-br-sil Healthcare Journal of Oregon en PressRelease 2026-05-08T10:30:00+00:00 Thérapeutique Knight annonce l’approbation réglementaire de TAVALISSE® au Brésil https://ml.globenewswire.com/media/e9457092-692d-4bfd-b361-9799ee8d73cd/small/logo-knight-256x256px-jpg.jpg https://www.healthcarejournaloregon.com/article/911340666-artiva-announces-positive-initial-clinical-data-with-allonk-across-multiple-autoimmune-diseases-and-fda-alignment-to-initiate-phase-3-registrational Healthcare Journal of Oregon en PressRelease 2026-05-08T10:30:00+00:00 Artiva Announces Positive Initial Clinical Data with AlloNK® Across Multiple Autoimmune Diseases and FDA Alignment to Initiate Phase 3 Registrational Trial in Rheumatoid Arthritis in 2026 https://ml.globenewswire.com/media/0392544b-ecff-4590-9eed-59c934e1ba4d/small/artiva-biotherapeutics-logo-jpg.jpg https://www.healthcarejournaloregon.com/article/911340599-nxera-files-patent-infringement-action-in-relation-to-its-minig-platform-technology Healthcare Journal of Oregon en PressRelease 2026-05-08T10:26:31+00:00 Nxera Files Patent Infringement Action in Relation to its miniG Platform Technology https://ml-eu.globenewswire.com/media/5cc74d52-c86f-4e21-8684-3496281fee15/small/nxera-master-logo-rgb-black-1-png.png https://www.healthcarejournaloregon.com/article/911340746-angel-expands-u-s-water-purification-lineup-with-new-whole-house-water-filtration-systems Healthcare Journal of Oregon en PressRelease 2026-05-08T10:20:18+00:00 ANGEL Expands U.S. Water Purification Lineup with New Whole House Water Filtration Systems https://ml.globenewswire.com/media/c9f92ea2-5454-4357-8a0b-3955c66106f3/medium/image-1.jpeg https://www.healthcarejournaloregon.com/article/911340682-profusa-receives-favorable-nasdaq-listing-determination Healthcare Journal of Oregon en PressRelease 2026-05-08T10:00:00+00:00 Profusa Receives Favorable Nasdaq Listing Determination https://ml.globenewswire.com/media/a8137a61-b858-48da-9e47-1f1bf8f6ddba/small/profusa-logo-jpg.jpg https://www.healthcarejournaloregon.com/article/911340704-pharvaris-announces-pricing-of-115-million-underwritten-offering-of-ordinary-shares Healthcare Journal of Oregon en PressRelease 2026-05-08T10:00:00+00:00 Pharvaris Announces Pricing of $115 Million Underwritten Offering of Ordinary Shares https://ml.globenewswire.com/media/4f758956-d75c-4020-9df0-b14d01115a1b/small/pharvaris-logo-png.png https://www.healthcarejournaloregon.com/article/911307449-update-on-fda-priority-review-of-leqembi-iqlik-lecanemab-irmb-subcutaneous-injection-as-a-starting-dose-for-early-alzheimer-s-disease Healthcare Journal of Oregon en PressRelease 2026-05-08T06:30:00+00:00 Update on FDA Priority Review of LEQEMBI® IQLIK™ (lecanemab-irmb) Subcutaneous Injection as a Starting Dose for Early Alzheimer’s Disease https://ml.globenewswire.com/media/80f9c524-3da2-4583-a763-0dad931fa182/small/biogen-logo-standard-rgb-r-jpg.jpg https://www.healthcarejournaloregon.com/article/911111438-navex-appoints-arpan-sheth-as-chief-executive-officer Healthcare Journal of Oregon en PressRelease 2026-05-07T16:32:13+00:00 NAVEX Appoints Arpan Sheth as Chief Executive Officer https://www.healthcarejournaloregon.com/article/911268606-lifestance-health-group-announces-pricing-of-secondary-public-offering Healthcare Journal of Oregon en PressRelease 2026-05-08T02:18:18+00:00 LifeStance Health Group Announces Pricing of Secondary Public Offering https://ml.globenewswire.com/media/08b345f0-a6a4-4217-9255-cce40df2585c/small/lifestance-logo-png.png https://www.healthcarejournaloregon.com/article/911254150-mobia-medical-announces-pricing-of-initial-public-offering Healthcare Journal of Oregon en PressRelease 2026-05-08T02:10:05+00:00 Mobia Medical Announces Pricing of Initial Public Offering https://ml.globenewswire.com/media/52324ae5-4190-4acb-93b4-aa6f1c996843/small/mobia-medical-logo-color-rgb-400x400-png.png https://www.healthcarejournaloregon.com/article/911082144-boulder-care-appoints-optum-behavioral-health-executive-andy-kelly-as-first-ever-chief-commercial-officer Healthcare Journal of Oregon en PressRelease 2026-05-07T14:00:00+00:00 Boulder Care Appoints Optum Behavioral Health Executive Andy Kelly as First-Ever Chief Commercial Officer https://d2c0db5b8fb27c1c9887-9b32efc83a6b298bb22e7a1df0837426.ssl.cf2.rackcdn.com/24850091-andy-kelly-1242x1874.png https://www.healthcarejournaloregon.com/article/911239138-odyssey-therapeutics-announces-pricing-of-upsized-initial-public-offering Healthcare Journal of Oregon en PressRelease 2026-05-08T00:44:45+00:00 Odyssey Therapeutics Announces Pricing of Upsized Initial Public Offering https://ml.globenewswire.com/media/6da00a97-4976-4d32-9f38-cff9c4f091cf/small/odysseylogo-color-highres-png.png https://www.healthcarejournaloregon.com/article/911239126-innocare-announces-approval-of-a-phase-ii-clinical-trial-of-tyk2-inhibitor-icp-488-for-sj-gren-s-syndrome-in-china Healthcare Journal of Oregon en PressRelease 2026-05-08T00:30:00+00:00 InnoCare Announces Approval of a Phase II Clinical Trial of TYK2 Inhibitor ICP-488 for Sjögren's Syndrome in China https://ml.globenewswire.com/media/2dc70b00-a0b0-4d85-adef-2717a7067aec/small/innocare-eng-logo-horizontal-png.png https://www.healthcarejournaloregon.com/article/911239075-medipharm-labs-sets-date-to-report-first-quarter-2026-financial-results Healthcare Journal of Oregon en PressRelease 2026-05-08T00:05:00+00:00 MediPharm Labs Sets Date to Report First Quarter 2026 Financial Results https://ml.globenewswire.com/media/7a534238-60aa-4187-979d-8f4d83fa58c1/small/medipharm-logo-jpg.jpg https://www.healthcarejournaloregon.com/article/911222901-cue-biopharma-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Healthcare Journal of Oregon en PressRelease 2026-05-07T23:07:21+00:00 Cue Biopharma Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/10541379-34cc-4869-a26f-fd99feead42a/small/cue-bio-brand-strategy-graphics-jpg.jpg https://www.healthcarejournaloregon.com/article/911222877-novi-glp-1-weight-loss-claims-evaluated-trusted-semaglutide-tirzepatide-prescription-medication-treatment-options-with-dedicated-doctors Healthcare Journal of Oregon en PressRelease 2026-05-07T22:50:39+00:00 Novi GLP-1 Weight Loss Claims Evaluated: Trusted Semaglutide & Tirzepatide Prescription Medication Treatment Options with Dedicated Doctors https://zingfast.com/wp-content/uploads/2026/05/Novi-GLP-1-Weight-Loss.jpg https://www.healthcarejournaloregon.com/article/911207186-biosyent-schedules-first-quarter-2026-earnings-release-for-may-14-2026 Healthcare Journal of Oregon en PressRelease 2026-05-07T22:11:05+00:00 BioSyent Schedules First Quarter 2026 Earnings Release for May 14, 2026 https://ml.globenewswire.com/media/3dded277-7953-4418-be63-7d7a3067811d/small/biosyent-logo-png.png https://www.healthcarejournaloregon.com/article/911207122-vitalhub-reports-first-quarter-2026-results Healthcare Journal of Oregon en PressRelease 2026-05-07T21:55:00+00:00 VitalHub Reports First Quarter 2026 Results https://ml.globenewswire.com/media/fae8da93-7d5e-4eb4-9121-d724c8555bce/small/greylogo-png.png https://www.healthcarejournaloregon.com/article/911207124-vitalhub-announces-planned-board-succession-with-appointment-of-allan-brett-as-chairman Healthcare Journal of Oregon en PressRelease 2026-05-07T21:55:00+00:00 VitalHub Announces Planned Board Succession with Appointment of Allan Brett as Chairman https://ml.globenewswire.com/media/fae8da93-7d5e-4eb4-9121-d724c8555bce/small/greylogo-png.png https://www.healthcarejournaloregon.com/article/911207026-extendicare-announces-2026-first-quarter-results Healthcare Journal of Oregon en PressRelease 2026-05-07T21:24:42+00:00 Extendicare Announces 2026 First Quarter Results https://ml.globenewswire.com/media/6d631964-eede-4e2c-912c-58ab7d1dc35f/small/extendicare-jpg.jpg https://www.healthcarejournaloregon.com/article/911190966-lemaitre-to-present-at-the-bank-of-america-healthcare-conference Healthcare Journal of Oregon en PressRelease 2026-05-07T21:15:30+00:00 LeMaitre to Present at the Bank of America Healthcare Conference https://ml.globenewswire.com/media/8b8755b7-6f04-4650-9c94-0a2d0654fd49/small/lemaitre-2color-rgb-jpg.jpg https://www.healthcarejournaloregon.com/article/911190225-nova-leap-health-corp-posts-q1-2026-results Healthcare Journal of Oregon en PressRelease 2026-05-07T21:00:00+00:00 Nova Leap Health Corp. Posts Q1 2026 Results https://ml.globenewswire.com/media/a1093558-bfa0-423d-827b-10c04fa3374d/medium/revenue-in-usd.png https://www.healthcarejournaloregon.com/article/911190801-tarsus-to-participate-in-upcoming-investor-conferences Healthcare Journal of Oregon en PressRelease 2026-05-07T21:00:00+00:00 Tarsus to Participate in Upcoming Investor Conferences https://ml.globenewswire.com/media/22d429f7-9b81-4c03-a147-1d9cbc86d1dd/small/tarsus-logo-stacked-color-532x626-png.png https://www.healthcarejournaloregon.com/article/911190911-lifestance-health-group-announces-launch-of-secondary-public-offering Healthcare Journal of Oregon en PressRelease 2026-05-07T20:51:06+00:00 LifeStance Health Group Announces Launch of Secondary Public Offering https://ml.globenewswire.com/media/08b345f0-a6a4-4217-9255-cce40df2585c/small/lifestance-logo-png.png https://www.healthcarejournaloregon.com/article/911190000-xilio-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Healthcare Journal of Oregon en PressRelease 2026-05-07T20:30:00+00:00 Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/7e55cc25-f46f-423c-bf2a-e77ebaf69665/small/xilio-full-clr-logo-cmyk-png.png https://www.healthcarejournaloregon.com/article/911190089-opus-genetics-presents-clinical-and-preclinical-data-at-arvo-2026-demonstrating-continued-pipeline-advancement-in-inherited-retinal-diseases Healthcare Journal of Oregon en PressRelease 2026-05-07T20:30:00+00:00 Opus Genetics Presents Clinical and Preclinical Data at ARVO 2026 Demonstrating Continued Pipeline Advancement in Inherited Retinal Diseases https://ml.globenewswire.com/media/468baef1-3b2d-4353-a17e-cb41b45ee6ef/small/opus-rgb-r-jpg.jpg https://www.healthcarejournaloregon.com/article/911190241-steris-appoints-pierre-boulud-to-board-of-directors Healthcare Journal of Oregon en PressRelease 2026-05-07T20:30:00+00:00 STERIS Appoints Pierre Boulud to Board of Directors https://ml.globenewswire.com/media/2c1a9c6d-bc94-4d3f-a47f-0ac0d209f8b6/small/sterishoriz-no-r-rgb-jpg-jpg.jpg https://www.healthcarejournaloregon.com/article/911190332-netramark-announces-change-to-board-of-directors Healthcare Journal of Oregon en PressRelease 2026-05-07T20:30:00+00:00 NetraMark Announces Change To Board Of Directors https://ml.globenewswire.com/media/d65cf3f8-cf9c-475c-b740-09a659269da4/small/netramark-word-eye-blk-jpg.jpg https://www.healthcarejournaloregon.com/article/911190364-in8bio-reports-first-quarter-2026-financial-results-and-recent-business-highlights Healthcare Journal of Oregon en PressRelease 2026-05-07T20:30:00+00:00 IN8bio Reports First Quarter 2026 Financial Results and Recent Business Highlights https://ml.globenewswire.com/media/ab4056e8-16d0-4c44-9ee8-367a47f6ef78/small/in8biologo-jpg.jpg https://www.healthcarejournaloregon.com/article/911190016-cytomx-therapeutics-announces-q1-2026-financial-results-and-provides-business-update Healthcare Journal of Oregon en PressRelease 2026-05-07T20:15:00+00:00 CytomX Therapeutics Announces Q1 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/c252869d-a4c1-4e56-88e8-d80b85d20c35/small/cytomx-logo-jpg.jpg https://www.healthcarejournaloregon.com/article/911190215-amn-healthcare-announces-first-quarter-2026-results Healthcare Journal of Oregon en PressRelease 2026-05-07T20:15:00+00:00 AMN Healthcare Announces First Quarter 2026 Results https://ml.globenewswire.com/media/7ac9ce26-e0ee-41e1-94d5-cf8155014873/small/large-amn-logo-wtagline-jpg.jpg https://www.healthcarejournaloregon.com/article/911190232-globus-medical-reports-first-quarter-2026-results Healthcare Journal of Oregon en PressRelease 2026-05-07T20:15:00+00:00 Globus Medical Reports First Quarter 2026 Results https://ml.globenewswire.com/media/46f81a86-b794-42b0-bf72-63447eb13f53/small/gmlogo-2024-rgb-high-png.png https://www.healthcarejournaloregon.com/article/911190375-cognition-therapeutics-reports-financial-results-for-the-first-quarter-2026-and-provides-business-update Healthcare Journal of Oregon en PressRelease 2026-05-07T20:15:00+00:00 Cognition Therapeutics Reports Financial Results for the First Quarter 2026 and Provides Business Update https://ml.globenewswire.com/media/a14fd627-7ccb-45e2-95fe-792bbfb83231/small/2020-0227-cognition-logo-for-gnw-png.png https://www.healthcarejournaloregon.com/article/911190538-genelux-corporation-reports-first-quarter-financial-results-and-provides-business-updates Healthcare Journal of Oregon en PressRelease 2026-05-07T20:15:00+00:00 Genelux Corporation Reports First Quarter Financial Results and Provides Business Updates https://ml.globenewswire.com/media/a4117c65-91cf-479d-9a61-b3edfddde26f/small/genelux-final-logo-notagline-png.png https://www.healthcarejournaloregon.com/article/911190583-restoring-the-biology-of-hair-growth-at-its-root-mblue-labs-launches-next-generation-hair-regeneration-technology Healthcare Journal of Oregon en PressRelease 2026-05-07T20:12:37+00:00 Restoring the Biology of Hair Growth at its Root: Mblue Labs Launches Next-Generation Hair Regeneration Technology https://ml.globenewswire.com/media/d60c091d-85a3-4cd0-9150-e865a3dfdff9/medium/mblue-labs-launches-next-generation-hair-regeneration-techno.png https://www.healthcarejournaloregon.com/article/911173728-milestone-scientific-schedules-first-quarter-2026-financial-results-and-business-update-conference-call Healthcare Journal of Oregon en PressRelease 2026-05-07T20:10:00+00:00 Milestone Scientific Schedules First Quarter 2026 Financial Results and Business Update Conference Call https://ml.globenewswire.com/media/408ad3c5-6ad3-41bd-9763-356666216796/small/milestonelogo-rgb-final-jpg.jpg https://www.healthcarejournaloregon.com/article/911174316-omada-health-joins-lilly-employer-connect-expanding-its-access-pathways-for-glp-1-care-as-patients-seek-more-lifestyle-support Healthcare Journal of Oregon en PressRelease 2026-05-07T20:10:00+00:00 Omada Health Joins Lilly Employer Connect, Expanding Its Access Pathways for GLP-1 Care as Patients Seek More Lifestyle Support https://ml.globenewswire.com/media/f60ce57f-1859-49c3-9423-9562cf46cb64/small/omada-horizontal-color-r-png.png https://www.healthcarejournaloregon.com/article/911173636-nephros-announces-financial-results-for-quarter-ended-march-31-2026 Healthcare Journal of Oregon en PressRelease 2026-05-07T20:05:00+00:00 Nephros Announces Financial Results for Quarter Ended March 31, 2026 https://ml.globenewswire.com/media/47f2ed6d-a81f-4174-a3eb-0a46a538285e/small/logo-png.png https://www.healthcarejournaloregon.com/article/911173647-madrigal-pharmaceuticals-announces-grants-of-inducement-awards-under-nasdaq-listing-rule-5635-c-4 Healthcare Journal of Oregon en PressRelease 2026-05-07T20:05:00+00:00 Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/8fec8de1-1a2e-4f6c-a679-fc43002276ba/small/madrigal-logo-jpg.jpg https://www.healthcarejournaloregon.com/article/911173688-tela-bio-announces-inducement-grants-under-nasdaq-listing-rule-5635-c-4 Healthcare Journal of Oregon en PressRelease 2026-05-07T20:05:00+00:00 TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://ml.globenewswire.com/media/62aad9be-813a-415e-990b-f27442cbec50/small/download-png.png https://www.healthcarejournaloregon.com/article/911173700-jade-biosciences-reports-first-quarter-2026-financial-results-and-provides-corporate-update Healthcare Journal of Oregon en PressRelease 2026-05-07T20:05:00+00:00 Jade Biosciences Reports First Quarter 2026 Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/74b5b00e-9a9e-4581-801b-a6e2ddab3aab/small/jade-logo-full-color-rgb-jpg.jpg https://www.healthcarejournaloregon.com/article/911173748-nextcure-provides-business-update-and-reports-first-quarter-2026-financial-results Healthcare Journal of Oregon en PressRelease 2026-05-07T20:05:00+00:00 NextCure Provides Business Update and Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/df24cd65-0f3d-4ede-9e7a-c3f58ce6e9d4/small/logo-nextcure-jpg.jpg https://www.healthcarejournaloregon.com/article/911173756-pyxis-oncology-appoints-nelson-azoulay-as-chief-business-officer Healthcare Journal of Oregon en PressRelease 2026-05-07T20:05:00+00:00 Pyxis Oncology Appoints Nelson Azoulay as Chief Business Officer https://ml.globenewswire.com/media/d3b77f06-3f52-42af-8f38-e3fda9c8025b/small/pyxis-logo-jpg.jpg https://www.healthcarejournaloregon.com/article/911173778-skinhealth-systems-reports-first-quarter-2026-financial-results Healthcare Journal of Oregon en PressRelease 2026-05-07T20:05:00+00:00 SkinHealth Systems Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/187132d2-7aef-4a14-8cd2-07829cc11496/small/skinhealthsystems-logo-black-jpg.jpg https://www.healthcarejournaloregon.com/article/911173803-myriad-genetics-to-participate-in-upcoming-investor-healthcare-conferences Healthcare Journal of Oregon en PressRelease 2026-05-07T20:05:00+00:00 Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences https://ml.globenewswire.com/media/5cb679cf-5a10-4b95-8cf7-fd1d0b56721a/small/myriad-s-stacked-png.png https://www.healthcarejournaloregon.com/article/911173806-camp4-reports-first-quarter-2026-financial-results-and-corporate-highlights Healthcare Journal of Oregon en PressRelease 2026-05-07T20:05:00+00:00 CAMP4 Reports First Quarter 2026 Financial Results and Corporate Highlights https://ml.globenewswire.com/media/72048fc6-0a8d-4ed2-9be8-ec0ee0afd8ba/small/cmp4-21-logo-full-color-jpg.jpg https://www.healthcarejournaloregon.com/article/911173815-immucell-to-announce-unaudited-financial-results-for-the-quarter-ended-march-31-2026 Healthcare Journal of Oregon en PressRelease 2026-05-07T20:05:00+00:00 ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2026 https://ml.globenewswire.com/media/680330c2-368b-4abc-9429-878b0c9fb1a2/small/immucell-jpg.jpg https://www.healthcarejournaloregon.com/article/911173820-4dmt-reports-first-quarter-2026-financial-results-operational-highlights-and-expected-upcoming-milestones Healthcare Journal of Oregon en PressRelease 2026-05-07T20:05:00+00:00 4DMT Reports First Quarter 2026 Financial Results, Operational Highlights and Expected Upcoming Milestones https://ml.globenewswire.com/media/027d40cf-145a-47b2-a0b8-823759376823/small/logo-2x-png.png https://www.healthcarejournaloregon.com/article/911173903-organogenesis-holdings-inc-reports-first-quarter-2026-financial-results Healthcare Journal of Oregon en PressRelease 2026-05-07T20:05:00+00:00 Organogenesis Holdings Inc. Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/9c2f551f-b7b2-403a-bf43-78f1889401e5/small/organogenesis-jpg.jpg https://www.healthcarejournaloregon.com/article/911174061-zymeworks-provides-corporate-update-and-reports-first-quarter-2026-financial-results Healthcare Journal of Oregon en PressRelease 2026-05-07T20:05:00+00:00 Zymeworks Provides Corporate Update and Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/de376a45-7a16-49db-8ad4-65ff45472c90/small/zymeworks-logo-color-png.png https://www.healthcarejournaloregon.com/article/911174243-imagenebio-reports-first-quarter-2026-financial-results-and-provides-img-007-program-update Healthcare Journal of Oregon en PressRelease 2026-05-07T20:05:00+00:00 ImageneBio Reports First Quarter 2026 Financial Results and Provides IMG-007 Program Update https://ml.globenewswire.com/media/ccccc30d-a51c-48d7-9aec-6b542240c611/small/imagene-logo-green-jpg.jpg https://www.healthcarejournaloregon.com/article/911174248-crinetics-pharmaceuticals-reports-first-quarter-2026-financial-results-and-provides-business-update Healthcare Journal of Oregon en PressRelease 2026-05-07T20:05:00+00:00 Crinetics Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/ff5e7cfa-b9fb-4679-8bf3-6e9d25207b83/small/crinetics-logo-trademark-jpg-1-jpg.jpg https://www.healthcarejournaloregon.com/article/911174271-the-joint-corp-reports-first-quarter-2026-financial-results Healthcare Journal of Oregon en PressRelease 2026-05-07T20:05:00+00:00 The Joint Corp. Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/ca375acf-3959-4292-8efa-e64eeeca3ed0/small/jynt-792x612px-1-png.png https://www.healthcarejournaloregon.com/article/911174297-atsena-presents-positive-clinical-data-from-its-xlrs-and-lca1-gene-therapy-programs-at-arvo-2026 Healthcare Journal of Oregon en PressRelease 2026-05-07T20:05:00+00:00 Atsena Presents Positive Clinical Data from Its XLRS and LCA1 Gene Therapy Programs at ARVO 2026 https://ml.globenewswire.com/media/90d0bd84-4404-435c-9875-3473b4cc7172/small/atsena-logo-jpg.jpg https://www.healthcarejournaloregon.com/article/911174303-werewolf-therapeutics-reports-first-quarter-2026-financial-results-and-recent-corporate-updates Healthcare Journal of Oregon en PressRelease 2026-05-07T20:05:00+00:00 Werewolf Therapeutics Reports First Quarter 2026 Financial Results and Recent Corporate Updates https://ml.globenewswire.com/media/afa0b662-d7e8-40d2-aad4-824ccfcaddd5/small/wolf-jpg.jpg https://www.healthcarejournaloregon.com/article/911174348-aligos-therapeutics-reports-recent-business-progress-and-first-quarter-2026-financial-results Healthcare Journal of Oregon en PressRelease 2026-05-07T20:05:00+00:00 Aligos Therapeutics Reports Recent Business Progress and First Quarter 2026 Financial Results https://ml.globenewswire.com/media/03ffbe89-c47f-4f83-b51f-f13a572e2cd1/small/aligos-png.png https://www.healthcarejournaloregon.com/article/911174508-leonabio-reports-first-quarter-2026-financial-results-and-provides-business-update Healthcare Journal of Oregon en PressRelease 2026-05-07T20:05:00+00:00 LeonaBio Reports First Quarter 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/84ac024a-139b-463f-a43f-ed787a66c0fd/small/image1-jpg.jpg https://www.healthcarejournaloregon.com/article/911174548-codexis-reports-first-quarter-2026-financial-results Healthcare Journal of Oregon en PressRelease 2026-05-07T20:05:00+00:00 Codexis Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/ebbfa755-c2db-4783-aace-43c700ba3369/small/codexis-logo-september-2023-png.png https://www.healthcarejournaloregon.com/article/911174676-profound-medical-reports-strong-first-quarter-2026-financial-results Healthcare Journal of Oregon en PressRelease 2026-05-07T20:05:00+00:00 Profound Medical Reports Strong First Quarter 2026 Financial Results https://ml.globenewswire.com/media/94d9e057-9de3-430c-9a19-b41ff3e06a1e/small/profound-logo-cmyk-copy-jpg.jpg https://www.healthcarejournaloregon.com/article/911174680-icu-medical-announces-first-quarter-2026-results Healthcare Journal of Oregon en PressRelease 2026-05-07T20:05:00+00:00 ICU Medical Announces First Quarter 2026 Results https://ml.globenewswire.com/media/44f52bc4-1355-405c-bdac-609254095f19/small/icu-medical-logo-jpg.jpg https://www.healthcarejournaloregon.com/article/911174732-stryker-completes-acquisition-of-amplitude-vascular-systems-to-add-next-generation-ivl-technology-to-peripheral-vascular-portfolio Healthcare Journal of Oregon en PressRelease 2026-05-07T20:05:00+00:00 Stryker completes acquisition of Amplitude Vascular Systems to add next-generation IVL technology to peripheral vascular portfolio https://ml.globenewswire.com/media/c24fe8bd-9db6-4f42-8a52-06a4e1b673b5/small/stryker-logo2015-jpg.jpg https://www.healthcarejournaloregon.com/article/911174786-vaxart-provides-business-update-and-reports-first-quarter-2026-financial-results Healthcare Journal of Oregon en PressRelease 2026-05-07T20:05:00+00:00 Vaxart Provides Business Update and Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/aedaf06c-26f8-482c-ac72-39774eab2c35/small/vxrt-logo-jpg.png https://www.healthcarejournaloregon.com/article/911174797-structure-therapeutics-reports-first-quarter-2026-financial-results-and-recent-highlights Healthcare Journal of Oregon en PressRelease 2026-05-07T20:05:00+00:00 Structure Therapeutics Reports First Quarter 2026 Financial Results and Recent Highlights https://ml.globenewswire.com/media/154be1d7-62d7-4688-be20-3b2a10a2628e/small/structure-therapeutics-png.png https://www.healthcarejournaloregon.com/article/911174810-pacbio-announces-first-quarter-2026-financial-results Healthcare Journal of Oregon en PressRelease 2026-05-07T20:05:00+00:00 PacBio Announces First Quarter 2026 Financial Results https://ml.globenewswire.com/media/f408d681-e68c-4113-a7cd-be24486deefc/small/logo-centered-440x386-png.png https://www.healthcarejournaloregon.com/article/911174817-tomi-environmental-solutions-highlights-steramist-efficacy-in-neutralizing-biohazards-amid-rising-hantavirus-concerns Healthcare Journal of Oregon en PressRelease 2026-05-07T20:05:00+00:00 TOMI Environmental Solutions Highlights SteraMist Efficacy in Neutralizing Biohazards Amid Rising Hantavirus Concerns https://ml.globenewswire.com/media/f8c7c513-0121-4507-84b7-3680626d9cf3/small/tomi-jpg.jpg https://www.healthcarejournaloregon.com/article/911174975-cytek-biosciences-reports-first-quarter-2026-financial-results Healthcare Journal of Oregon en PressRelease 2026-05-07T20:05:00+00:00 Cytek Biosciences Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/5a33b17c-e545-48d8-b797-832cf8e4372c/small/cytek-logo-color-jpg.jpg https://www.healthcarejournaloregon.com/article/911174970-omada-health-reports-first-quarter-2026-results Healthcare Journal of Oregon en PressRelease 2026-05-07T20:03:25+00:00 Omada Health Reports First Quarter 2026 Results https://ml.globenewswire.com/media/f60ce57f-1859-49c3-9423-9562cf46cb64/small/omada-horizontal-color-r-png.png https://www.healthcarejournaloregon.com/article/911173695-outset-medical-reports-first-quarter-results Healthcare Journal of Oregon en PressRelease 2026-05-07T20:02:00+00:00 Outset Medical Reports First-Quarter Results https://ml.globenewswire.com/media/28778c78-03f1-4b17-9c13-3cc578c924dc/small/outset-id-orangegrey-png.png https://www.healthcarejournaloregon.com/article/911174896-catalyst-pharmaceuticals-cancels-first-quarter-2026-conference-call-and-webcast Healthcare Journal of Oregon en PressRelease 2026-05-07T20:02:00+00:00 Catalyst Pharmaceuticals Cancels First Quarter 2026 Conference Call and Webcast https://ml.globenewswire.com/media/960a6989-9f9c-4ad2-91cf-be10cebd6655/small/catalyst-pharmaceutical-logo.jpg https://www.healthcarejournaloregon.com/article/911173718-bluejay-diagnostics-provides-first-quarter-2026-corporate-update Healthcare Journal of Oregon en PressRelease 2026-05-07T20:01:00+00:00 Bluejay Diagnostics Provides First Quarter 2026 Corporate Update https://ml.globenewswire.com/media/d0d4a766-5115-448d-ba8a-d522100949f1/small/bjdx-jpg.jpg https://www.healthcarejournaloregon.com/article/911173810-celldex-reports-first-quarter-financial-results-and-provides-corporate-update Healthcare Journal of Oregon en PressRelease 2026-05-07T20:01:00+00:00 Celldex Reports First Quarter Financial Results and Provides Corporate Update https://ml.globenewswire.com/media/7a6cc287-087f-4e97-878f-7c1ed1dc5949/small/celldex-logo-rgb-png.png https://www.healthcarejournaloregon.com/article/911173830-tectonic-therapeutic-announces-first-quarter-2026-financial-results-and-recent-business-highlights Healthcare Journal of Oregon en PressRelease 2026-05-07T20:01:00+00:00 Tectonic Therapeutic Announces First Quarter 2026 Financial Results and Recent Business Highlights https://ml.globenewswire.com/media/7c13d2a1-2971-4ab0-a4b5-608923316546/small/tectonic-logo-full-color-png.png https://www.healthcarejournaloregon.com/article/911173866-xenon-reports-q1-2026-financial-results-and-provides-business-update Healthcare Journal of Oregon en PressRelease 2026-05-07T20:01:00+00:00 Xenon Reports Q1 2026 Financial Results and Provides Business Update https://ml.globenewswire.com/media/505b89d3-dfd1-46e8-bc3b-3c9c699ef7ec/small/xenon-logo-tm-full-color-250x80px-png.png https://www.healthcarejournaloregon.com/article/911173899-bridgebio-reports-first-quarter-2026-financial-results-and-corporate-updates Healthcare Journal of Oregon en PressRelease 2026-05-07T20:01:00+00:00 BridgeBio Reports First Quarter 2026 Financial Results and Corporate Updates https://ml.globenewswire.com/media/2074ba9b-0e5b-41fa-baac-553f1345bb75/small/bridge-bio-black-png.png https://www.healthcarejournaloregon.com/article/911174023-voyager-reports-first-quarter-2026-financial-and-operating-results Healthcare Journal of Oregon en PressRelease 2026-05-07T20:01:00+00:00 Voyager Reports First Quarter 2026 Financial and Operating Results https://ml.globenewswire.com/media/f775f55a-83dd-4b38-bf92-bb9b588522bd/small/voyager-logos-square-logo-light-png.png https://www.healthcarejournaloregon.com/article/911174055-senseonics-holdings-inc-reports-first-quarter-2026-financial-results Healthcare Journal of Oregon en PressRelease 2026-05-07T20:01:00+00:00 Senseonics Holdings, Inc. Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/7f64f449-dd5d-4bd1-9504-82adb3846669/small/logo-png.png https://www.healthcarejournaloregon.com/article/911174167-siga-reports-financial-results-for-three-months-ended-march-31-2026-and-provides-business-update Healthcare Journal of Oregon en PressRelease 2026-05-07T20:01:00+00:00 SIGA Reports Financial Results for Three Months Ended March 31, 2026 and Provides Business Update https://ml.globenewswire.com/media/93028aa6-8191-4392-a7b1-447b046cd93b/small/siga-logo-blue-png.png https://www.healthcarejournaloregon.com/article/911174322-annexon-reports-first-quarter-2026-financial-results-portfolio-progress-and-key-anticipated-milestones Healthcare Journal of Oregon en PressRelease 2026-05-07T20:01:00+00:00 Annexon Reports First Quarter 2026 Financial Results, Portfolio Progress and Key Anticipated Milestones https://ml.globenewswire.com/media/fda933a1-e95d-4cae-8894-7b2354118e20/small/annexon-logo-rgb-png.png https://www.healthcarejournaloregon.com/article/911174427-denali-therapeutics-reports-first-quarter-2026-financial-results-and-business-highlights Healthcare Journal of Oregon en PressRelease 2026-05-07T20:01:00+00:00 Denali Therapeutics Reports First Quarter 2026 Financial Results and Business Highlights https://ml.globenewswire.com/media/898f19a9-f6ef-4d5a-8a4f-27709b81609a/small/denali-green-logo-png.png https://www.healthcarejournaloregon.com/article/911174446-corvus-pharmaceuticals-provides-business-update-and-reports-first-quarter-2026-financial-results Healthcare Journal of Oregon en PressRelease 2026-05-07T20:01:00+00:00 Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/d05c16d1-5c24-4242-84b5-aea3951ca251/small/corvus-logo-large-jpg.jpg https://www.healthcarejournaloregon.com/article/911174703-progyny-inc-announces-first-quarter-2026-results Healthcare Journal of Oregon en PressRelease 2026-05-07T20:01:00+00:00 Progyny, Inc. Announces First Quarter 2026 Results https://ml.globenewswire.com/media/1342dacd-99c3-4043-af8a-2fd5e9ea569f/small/progyny-203860-no-tag-png.png https://www.healthcarejournaloregon.com/article/911174783-amneal-reports-first-quarter-2026-financial-results Healthcare Journal of Oregon en PressRelease 2026-05-07T20:01:00+00:00 Amneal Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/a20d6f40-90af-422f-ab14-47208fdbad2f/small/amneal-rgb-k-png.png https://www.healthcarejournaloregon.com/article/911173712-assembly-biosciences-reports-first-quarter-2026-financial-results-and-recent-highlights Healthcare Journal of Oregon en PressRelease 2026-05-07T20:00:00+00:00 Assembly Biosciences Reports First Quarter 2026 Financial Results and Recent Highlights https://ml.globenewswire.com/media/33089548-b62b-412d-9343-ae38d8b720c6/small/assemblybio-logo-rgb-png.png https://www.healthcarejournaloregon.com/article/911173960-inmune-bio-inc-announces-first-quarter-2026-results-and-provides-business-update Healthcare Journal of Oregon en PressRelease 2026-05-07T20:00:00+00:00 INmune Bio Inc. Announces First Quarter 2026 Results and Provides Business Update https://ml.globenewswire.com/media/64035ec0-9fc2-414d-a693-27f1b1e90a31/small/logo-png.png https://www.healthcarejournaloregon.com/article/911174701-adcare-rhode-island-expands-addiction-treatment-access-for-underserved-south-county-by-moving-outpatient-services-to-its-north-kingstown-campus Healthcare Journal of Oregon en PressRelease 2026-05-07T20:00:00+00:00 AdCare Rhode Island Expands Addiction Treatment Access for Underserved South County by Moving Outpatient Services to its North Kingstown Campus https://ml.globenewswire.com/media/d184b31a-2896-48dd-8479-fc5c8cfc4b98/small/rhode-island-png.png https://www.healthcarejournaloregon.com/article/911174767-acumen-pharmaceuticals-to-participate-in-the-bank-of-america-securities-2026-health-care-conference Healthcare Journal of Oregon en PressRelease 2026-05-07T20:00:00+00:00 Acumen Pharmaceuticals to Participate in the Bank of America Securities 2026 Health Care Conference https://ml.globenewswire.com/media/53dd23f0-4b5b-4b6b-9dfa-22b5db4c922b/small/picture1-png.png https://www.healthcarejournaloregon.com/article/911174632-dragon-pharma-store-introduces-elevated-safety-protocols-for-peptide-product-distribution Healthcare Journal of Oregon en PressRelease 2026-05-07T19:25:00+00:00 Dragon Pharma Store Introduces Elevated Safety Protocols for Peptide Product Distribution https://ml.globenewswire.com/media/ecc49d09-485c-4b9b-8f06-2ad672e7cc52/medium/cover-image.jpg https://www.healthcarejournaloregon.com/article/911174609-the-invicta-gala-2026-raises-over-500-000-to-support-life-changing-care-for-veterans-and-first-responders Healthcare Journal of Oregon en PressRelease 2026-05-07T19:23:19+00:00 The INVICTA Gala 2026 Raises Over $500,000 to Support Life-Changing Care for Veterans and First Responders https://ml.globenewswire.com/media/YmJhN2ZlNmYtYTM3Yy00ZWZhLTllYzktMTgyMWMzNTlkN2VkLTEyMTMzODItMjAyNi0wNS0wNy1lbg==/tiny/Parker-University.png https://www.healthcarejournaloregon.com/article/911174379-leading-u-s-health-benefits-advocacy-group-honors-hii-with-2026-best-employers-award-for-excellence-in-health-care-value Healthcare Journal of Oregon en PressRelease 2026-05-07T19:15:00+00:00 Leading U.S. Health & Benefits Advocacy Group Honors HII with 2026 Best Employers Award for Excellence in Health Care Value https://ml.globenewswire.com/media/75212ee2-8c56-4924-840e-72fc2462672c/medium/2026-hii-healthcare-award.png https://www.healthcarejournaloregon.com/article/911158315-beacon-therapeutics-announces-positive-12-month-safety-and-efficacy-update-from-phase-2-dawn-trial-of-laru-zova-in-patients-with-x-linked-retinitis Healthcare Journal of Oregon en PressRelease 2026-05-07T19:00:00+00:00 Beacon Therapeutics Announces Positive 12-Month Safety and Efficacy Update from Phase 2 DAWN Trial of laru-zova in Patients with X-linked Retinitis Pigmentosa (XLRP) at ARVO 2026 Annual Meeting https://ml.globenewswire.com/media/020367be-8998-4af7-93ce-7c0c06f88bcd/small/beacon-logo-jpg.jpg https://www.healthcarejournaloregon.com/article/911143404-strengthening-mental-health-and-psychosocial-support-preparedness-in-emergencies Healthcare Journal of Oregon en PressRelease 2026-05-07T17:31:38+00:00 Strengthening Mental Health and Psychosocial Support Preparedness in Emergencies https://ml.globenewswire.com/media/1b65a0f4-01af-440a-b778-9b5a8e3dc4f2/small/red-cross-png.png https://www.healthcarejournaloregon.com/article/911143408-renforcement-des-services-en-sant-mentale-et-bien-tre-en-pr-paration-aux-situations-d-urgence Healthcare Journal of Oregon en PressRelease 2026-05-07T17:31:38+00:00 Renforcement des services en santé mentale et bien-être en préparation aux situations d’urgence https://ml.globenewswire.com/media/1b65a0f4-01af-440a-b778-9b5a8e3dc4f2/small/red-cross-png.png https://www.healthcarejournaloregon.com/article/911143395-inviah-launches-beta-in-chicago-the-doctor-comes-to-you Healthcare Journal of Oregon en PressRelease 2026-05-07T17:20:50+00:00 INVIAH Launches Beta in Chicago: The Doctor Comes to You https://ml.globenewswire.com/media/5faca65e-08a3-4dd0-a67a-62790f6063cd/medium/inivah-co-founders-dr-yevhen-pavelko-and-natallia-panysh.jpeg https://www.healthcarejournaloregon.com/article/911143321-serotonin-centers-highlights-5-day-live-training-program-as-cornerstone-of-franchise-support-and-performance Healthcare Journal of Oregon en PressRelease 2026-05-07T17:18:00+00:00 Serotonin Centers Highlights 5-Day Live Training Program as Cornerstone of Franchise Support and Performance https://ml.globenewswire.com/media/6d8d9de0-ab7b-477e-b683-4db07437bee6/medium/serotonin-centers-5-day-live-training-session.png https://www.healthcarejournaloregon.com/article/911143280-glucotrack-announces-ide-submission-for-u-s-clinical-study-of-its-novel-implantable-continuous-blood-glucose-monitoring-technology Healthcare Journal of Oregon en PressRelease 2026-05-07T17:00:00+00:00 Glucotrack Announces IDE Submission for U.S. Clinical Study of its Novel Implantable Continuous Blood Glucose Monitoring Technology https://ml.globenewswire.com/media/3e47bd1b-0cc6-4104-b91d-0ddb9f30f4cc/small/gt-logo-png.png https://www.healthcarejournaloregon.com/article/911143308-the-helios-alliance-applauds-dr-rahul-gupta-s-appointment-to-knoa-foundation-board-of-trustees Healthcare Journal of Oregon en PressRelease 2026-05-07T16:52:00+00:00 The Helios Alliance Applauds Dr. Rahul Gupta's Appointment to Knoa Foundation Board of Trustees https://pressranger.s3.us-west-1.amazonaws.com/3259151/dr-rahul-gupta-headshot.jpg https://www.healthcarejournaloregon.com/article/911143360-sk-pharmteco-arbeitet-mit-axle-informatics-und-den-national-institutes-of-health-zusammen-um-gentherapieprogramme-bei-seltenen-krankheiten Healthcare Journal of Oregon en PressRelease 2026-05-07T16:49:14+00:00 SK pharmteco arbeitet mit Axle Informatics und den National Institutes of Health zusammen, um Gentherapieprogramme bei seltenen Krankheiten voranzutreiben https://ml.globenewswire.com/media/038236c2-8cb0-4ff3-8b7e-cbb02b768b37/small/sk-pharmteco-3-png.png https://www.healthcarejournaloregon.com/article/911143363-sk-pharmteco-collabore-avec-axle-informatics-et-les-instituts-nationaux-de-la-sant-afin-de-d-velopper-des-programmes-de-th-rapie-g-nique-pour-les Healthcare Journal of Oregon en PressRelease 2026-05-07T16:49:14+00:00 SK pharmteco collabore avec Axle Informatics et les Instituts nationaux de la santé afin de développer des programmes de thérapie génique pour les maladies rares https://ml.globenewswire.com/media/038236c2-8cb0-4ff3-8b7e-cbb02b768b37/small/sk-pharmteco-3-png.png https://www.healthcarejournaloregon.com/article/911128648-biorestorative-therapies-reports-expanded-phase-2-blinded-dataset-for-brtx-100-showing-sustained-pain-and-functional-improvements-in-chronic-lumbar Healthcare Journal of Oregon en PressRelease 2026-05-07T16:00:00+00:00 BioRestorative Therapies Reports Expanded Phase 2 Blinded Dataset for BRTX-100 Showing Sustained Pain and Functional Improvements in Chronic Lumbar Disc Disease https://ml.globenewswire.com/media/a9a09a16-9f91-466d-a0b4-2a7f2fd05ebe/small/logo-png.png https://www.healthcarejournaloregon.com/article/911128669-tomi-environmental-solutions-binary-ionization-technology-approved-in-additional-european-union-countries Healthcare Journal of Oregon en PressRelease 2026-05-07T16:00:00+00:00 TOMI Environmental Solutions’ Binary Ionization Technology Approved in Additional European Union Countries https://ml.globenewswire.com/media/f8c7c513-0121-4507-84b7-3680626d9cf3/small/tomi-jpg.jpg https://www.healthcarejournaloregon.com/article/911128673-boyce-thompson-institute-names-dr-natalie-hoffmann-inaugural-jane-silverthorne-postdoctoral-fellow Healthcare Journal of Oregon en PressRelease 2026-05-07T15:44:00+00:00 Boyce Thompson Institute names Dr. Natalie Hoffmann inaugural Jane Silverthorne Postdoctoral Fellow https://pressranger.s3.us-west-1.amazonaws.com/3258963/NHoffmann.jpeg https://www.healthcarejournaloregon.com/article/911114154-sequel-med-tech-s-twiist-recognized-for-diabetes-management-innovation-in-2026-medtech-breakthrough-awards-program Healthcare Journal of Oregon en PressRelease 2026-05-07T15:05:00+00:00 Sequel Med Tech’s twiist™ Recognized for Diabetes Management Innovation in 2026 MedTech Breakthrough Awards Program https://ml.globenewswire.com/media/27a7520b-9ae6-414c-ae9d-5267dc364671/small/medtech-png.png https://www.healthcarejournaloregon.com/article/911114052-genmab-announces-financial-results-for-the-first-quarter-of-2026 Healthcare Journal of Oregon en PressRelease 2026-05-07T15:01:57+00:00 Genmab Announces Financial Results for the First Quarter of 2026 https://ml-eu.globenewswire.com/media/368a5dab-dfc5-4e1d-bfa6-2af5e5216fce/small/logo-jpg.jpg https://www.healthcarejournaloregon.com/article/911114147-trinetx-wins-clinical-trial-innovation-award-in-10th-annual-medtech-breakthrough-awards-program Healthcare Journal of Oregon en PressRelease 2026-05-07T15:00:00+00:00 TriNetX® Wins “Clinical Trial Innovation Award” in 10th Annual MedTech Breakthrough Awards Program https://ml.globenewswire.com/media/27a7520b-9ae6-414c-ae9d-5267dc364671/small/medtech-png.png https://www.healthcarejournaloregon.com/article/911114229-american-kidney-fund-s-sixth-annual-living-donor-protection-report-card-shows-progress-made-highlights-need-for-more-laws-and-regulations-to-protect Healthcare Journal of Oregon en PressRelease 2026-05-07T14:43:25+00:00 American Kidney Fund's Sixth Annual Living Donor Protection Report Card Shows Progress Made, Highlights Need for More Laws and Regulations to Protect Living Donors https://ml.globenewswire.com/media/NjAzYTViZDgtNWY5MS00NDJiLThmMjYtMDUxODcwNTk4NjViLTExMDkwNTItMjAyNi0wNS0wNy1lbg==/tiny/American-Kidney-Fund.png https://www.healthcarejournaloregon.com/article/911100485-proscia-wins-2026-medtech-breakthrough-award-for-turning-the-moment-of-diagnosis-into-drug-development-insights Healthcare Journal of Oregon en PressRelease 2026-05-07T14:15:00+00:00 Proscia Wins 2026 MedTech Breakthrough Award for Turning the Moment of Diagnosis into Drug Development Insights https://ml.globenewswire.com/media/4f416775-f097-4445-b40e-323fed394e00/small/proscia-png.png https://www.healthcarejournaloregon.com/article/911100410-chess-health-s-connections-app-named-best-mental-health-app Healthcare Journal of Oregon en PressRelease 2026-05-07T14:11:00+00:00 CHESS Health’s Connections App Named “Best Mental Health App” https://ml.globenewswire.com/media/YzQ2OTZlNjgtZmI3MS00MmI1LThjNjgtMjc1NmYwMTI2NTNjLTUwMDE0OTE0NS0yMDI2LTA1LTA3LWVu/tiny/CHESS-Health.png https://www.healthcarejournaloregon.com/article/911100479-bruno-vision-care-s-deseyne-wins-2026-medtech-breakthrough-award Healthcare Journal of Oregon en PressRelease 2026-05-07T14:05:00+00:00 Bruno Vision Care’s Deseyne® Wins 2026 MedTech Breakthrough Award https://ml.globenewswire.com/media/27a7520b-9ae6-414c-ae9d-5267dc364671/small/medtech-png.png https://www.healthcarejournaloregon.com/article/911100704-validic-inform-named-best-iot-healthcare-platform-in-2026-medtech-breakthrough-awards-program Healthcare Journal of Oregon en PressRelease 2026-05-07T14:02:45+00:00 Validic Inform Named “Best IoT Healthcare Platform” in 2026 MedTech Breakthrough Awards Program https://ml.globenewswire.com/media/5c89ea69-9ba7-4994-a816-9e0fe1f95b46/small/validic-logo-jpg.jpg https://www.healthcarejournaloregon.com/article/911100695-american-urological-association-releases-the-management-of-lower-urinary-tract-symptoms-attributed-to-benign-prostatic-hyperplasia-guideline Healthcare Journal of Oregon en PressRelease 2026-05-07T14:02:00+00:00 American Urological Association Releases the Management of Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia Guideline https://ml.globenewswire.com/media/M2I5YTU4NTMtMWYwNC00MzMyLWFiOGItMWNhYjdkNjhkMjU0LTEyNzYxOTAtMjAyNi0wNS0wNy1lbg==/tiny/American-Urological-Associatio.png https://www.healthcarejournaloregon.com/article/911100522-timelycare-wins-best-overall-telehealth-solution-in-2026-medtech-breakthrough-awards Healthcare Journal of Oregon en PressRelease 2026-05-07T14:01:00+00:00 TimelyCare Wins “Best Overall TeleHealth Solution” in 2026 MedTech Breakthrough Awards https://ml.globenewswire.com/media/92461aae-ee69-497b-af0f-1ef840643376/medium/medtech-breakthrough-best-overall-telehealth-solution.jpg https://www.healthcarejournaloregon.com/article/911100434-nsight-health-recognized-for-remote-patient-monitoring-innovation-in-2026-medtech-breakthrough-awards-program Healthcare Journal of Oregon en PressRelease 2026-05-07T14:00:00+00:00 Nsight Health Recognized for Remote Patient Monitoring Innovation in 2026 MedTech Breakthrough Awards Program https://ml.globenewswire.com/media/27a7520b-9ae6-414c-ae9d-5267dc364671/small/medtech-png.png https://www.healthcarejournaloregon.com/article/911100437-engen-wins-best-core-administrative-processing-system-designation-in-2026-medtech-breakthrough-awards-program Healthcare Journal of Oregon en PressRelease 2026-05-07T14:00:00+00:00 enGen Wins “Best Core Administrative Processing System” Designation in 2026 MedTech Breakthrough Awards Program https://ml.globenewswire.com/media/27a7520b-9ae6-414c-ae9d-5267dc364671/small/medtech-png.png https://www.healthcarejournaloregon.com/article/911100439-epredia-e1000-dx-digital-pathology-solution-named-best-new-diagnostic-technology-solution-in-2026-medtech-breakthrough-awards-program Healthcare Journal of Oregon en PressRelease 2026-05-07T14:00:00+00:00 Epredia E1000 Dx™ Digital Pathology Solution Named “Best New Diagnostic Technology Solution” in 2026 MedTech Breakthrough Awards Program https://ml.globenewswire.com/media/27a7520b-9ae6-414c-ae9d-5267dc364671/small/medtech-png.png https://www.healthcarejournaloregon.com/article/911100443-incannex-healthcare-recognized-for-innovative-drug-development-solutions-by-medtech-breakthrough Healthcare Journal of Oregon en PressRelease 2026-05-07T14:00:00+00:00 Incannex Healthcare Recognized for Innovative Drug Development Solutions by MedTech Breakthrough https://ml.globenewswire.com/media/27a7520b-9ae6-414c-ae9d-5267dc364671/small/medtech-png.png https://www.healthcarejournaloregon.com/article/911100446-evergen-named-best-overall-medtech-company-in-10th-annual-medtech-breakthrough-awards-program Healthcare Journal of Oregon en PressRelease 2026-05-07T14:00:00+00:00 Evergen Named “Best Overall MedTech Company” in 10th Annual MedTech Breakthrough Awards Program https://ml.globenewswire.com/media/27a7520b-9ae6-414c-ae9d-5267dc364671/small/medtech-png.png https://www.healthcarejournaloregon.com/article/911100468-castlight-health-named-best-healthcare-navigation-solution-in-10th-annual-medtech-breakthrough-awards-program Healthcare Journal of Oregon en PressRelease 2026-05-07T14:00:00+00:00 Castlight Health Named “Best Healthcare Navigation Solution” in 10th Annual MedTech Breakthrough Awards Program https://ml.globenewswire.com/media/27a7520b-9ae6-414c-ae9d-5267dc364671/small/medtech-png.png https://www.healthcarejournaloregon.com/article/911100473-aarete-s-behavioral-health-intelliscan-wins-2026-medtech-breakthrough-award Healthcare Journal of Oregon en PressRelease 2026-05-07T14:00:00+00:00 AArete’s Behavioral Health IntelliScan™ Wins 2026 MedTech Breakthrough Award https://ml.globenewswire.com/media/27a7520b-9ae6-414c-ae9d-5267dc364671/small/medtech-png.png https://www.healthcarejournaloregon.com/article/911100482-suvoda-patient-app-earns-best-patient-relationship-management-solution-in-2026-medtech-breakthrough-awards-program Healthcare Journal of Oregon en PressRelease 2026-05-07T14:00:00+00:00 Suvoda Patient App Earns “Best Patient Relationship Management Solution” In 2026 MedTech Breakthrough Awards Program https://ml.globenewswire.com/media/27a7520b-9ae6-414c-ae9d-5267dc364671/small/medtech-png.png https://www.healthcarejournaloregon.com/article/911100493-a-decade-of-digital-health-innovation-medtech-breakthrough-announces-winners-of-the-10th-annual-awards-program Healthcare Journal of Oregon en PressRelease 2026-05-07T13:59:00+00:00 A Decade of Digital Health Innovation: MedTech Breakthrough Announces Winners of the 10th Annual Awards Program https://ml.globenewswire.com/media/27a7520b-9ae6-414c-ae9d-5267dc364671/small/medtech-png.png https://www.healthcarejournaloregon.com/article/911100668-standard-dental-labs-inc-closes-acquisition-of-brlit-dental-laboratory-increasing-revenue-base-by-more-than-375 Healthcare Journal of Oregon en PressRelease 2026-05-07T13:33:30+00:00 Standard Dental Labs Inc. Closes Acquisition of BRLIT Dental Laboratory, Increasing Revenue Base by More Than 375% https://ml.globenewswire.com/media/2369a47c-d78d-419f-acb4-14fafec588aa/small/sdl-logo-2023-02-png.png https://www.healthcarejournaloregon.com/article/911100587-maps-welcomes-liana-gillooly-and-andrew-mo-septimus-to-board-of-directors Healthcare Journal of Oregon en PressRelease 2026-05-07T13:30:00+00:00 MAPS Welcomes Liana Gillooly and Andrew "Mo" Septimus to Board of Directors https://ml.globenewswire.com/media/024e234c-e545-4328-9da2-a8bbb7ce7ca2/medium/liana-sananda-gillooly.png https://www.healthcarejournaloregon.com/article/911100635-leonabio-enhances-board-of-directors-with-appointments-of-fred-callori-j-d-natalie-holles-and-peter-b-silverman-j-d Healthcare Journal of Oregon en PressRelease 2026-05-07T13:20:00+00:00 LeonaBio Enhances Board of Directors with Appointments of Fred Callori, J.D., Natalie Holles and Peter B. Silverman, J.D. https://ml.globenewswire.com/media/84ac024a-139b-463f-a43f-ed787a66c0fd/small/image1-jpg.jpg https://www.healthcarejournaloregon.com/article/911088081-kraig-biocraft-laboratories-positions-itself-as-a-front-runner-in-spider-silk-race Healthcare Journal of Oregon en PressRelease 2026-05-07T13:05:00+00:00 Kraig Biocraft Laboratories Positions Itself as a Front-Runner in Spider Silk Race https://ml.globenewswire.com/media/N2U4N2NhMmQtYmQxOS00NTNlLTkyMTgtMTNjYWNlZTNhZTQ2LTUwMDE1MTA3NC0yMDI2LTA1LTA3LWVu/tiny/24-7-Market-News-and-Kraig-Lab.png https://www.healthcarejournaloregon.com/article/911087367-sk-pharmteco-collaborates-with-axle-informatics-and-the-national-institutes-of-health-to-advance-rare-disease-gene-therapy-programs Healthcare Journal of Oregon en PressRelease 2026-05-07T13:03:00+00:00 SK pharmteco Collaborates with Axle Informatics and the National Institutes of Health to Advance Rare Disease Gene Therapy Programs https://ml.globenewswire.com/media/038236c2-8cb0-4ff3-8b7e-cbb02b768b37/small/sk-pharmteco-3-png.png https://www.healthcarejournaloregon.com/article/911087163-novartis-breaks-ground-on-denton-texas-radioligand-therapy-site-construction-now-underway-across-all-new-us-facilities Healthcare Journal of Oregon en PressRelease 2026-05-07T13:00:00+00:00 Novartis breaks ground on Denton, Texas radioligand therapy site; construction now underway across all new US facilities https://ml-eu.globenewswire.com/media/f0161a05-9638-4da5-a4af-f9cdb28f0304/small/logo-warm-black-rgb-jpg.jpg https://www.healthcarejournaloregon.com/article/911087290-guidelight-health-launches-prism-an-lgbtqia-affirming-intensive-outpatient-program Healthcare Journal of Oregon en PressRelease 2026-05-07T13:00:00+00:00 Guidelight Health Launches Prism, an LGBTQIA+ Affirming Intensive Outpatient Program https://ml.globenewswire.com/media/9f7adafd-45c7-4a40-93c8-5fafd972ec99/medium/guidelight-central-park.jpg https://www.healthcarejournaloregon.com/article/911087305-after-milken-conference-a-saudi-cancer-center-highlights-the-metrics-behind-its-model Healthcare Journal of Oregon en PressRelease 2026-05-07T13:00:00+00:00 After Milken Conference, a Saudi Cancer Center Highlights the Metrics Behind Its Model https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://www.healthcarejournaloregon.com/article/911087357-tras-su-participaci-n-en-milken-institute-global-conference-2026-un-centro-oncol-gico-saud-destaca-los-indicadores-clave-de-su-modelo Healthcare Journal of Oregon en PressRelease 2026-05-07T13:00:00+00:00 Tras su participación en Milken Institute Global Conference 2026, un centro oncológico saudí destaca los indicadores clave de su modelo https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://www.healthcarejournaloregon.com/article/911087360-centro-de-c-ncer-da-ar-bia-saudita-revela-m-tricas-do-seu-modelo-depois-da-milken-conference Healthcare Journal of Oregon en PressRelease 2026-05-07T13:00:00+00:00 Centro de Câncer da Arábia Saudita Revela Métricas do seu Modelo Depois da Milken Conference https://ml.globenewswire.com/media/9f73a943-28c0-4ee7-a796-2407051abbe7/small/logo-kfshrc-png.png https://www.healthcarejournaloregon.com/article/911087387-asha-promotes-museum-exhibit-about-stuttering-for-national-stuttering-awareness-week Healthcare Journal of Oregon en PressRelease 2026-05-07T13:00:00+00:00 ASHA Promotes Museum Exhibit About Stuttering for National Stuttering Awareness Week https://ml.globenewswire.com/media/356ca2b0-0b3b-4b1b-b2c3-97e5adb4a972/small/ https://www.healthcarejournaloregon.com/article/911087391-alpha-tau-successfully-treats-first-pancreatic-cancer-patient-in-italy-with-alpha-dart-at-the-university-of-verona-s-pancreas-institute Healthcare Journal of Oregon en PressRelease 2026-05-07T13:00:00+00:00 Alpha Tau Successfully Treats First Pancreatic Cancer Patient in Italy with Alpha DaRT® at the University of Verona’s Pancreas Institute https://ml.globenewswire.com/media/a9de6f03-a487-4934-98e9-d25cdb4c8bed/small/atm-logo-jpg.jpg https://www.healthcarejournaloregon.com/article/911087403-cj-biomaterials-and-yuhan-kimberly-launch-world-s-first-reusable-nonwoven-paper-towel-made-with-amorphous-pha Healthcare Journal of Oregon en PressRelease 2026-05-07T13:00:00+00:00 CJ Biomaterials and Yuhan-Kimberly Launch World’s First Reusable Nonwoven Paper Towel Made with Amorphous PHA https://ml.globenewswire.com/media/d90773ea-9e82-43e9-8a28-b8055aec1d26/medium/cj-biomaterials-yuhan-kimberly-nonwoven-paper-towel.jpg https://www.healthcarejournaloregon.com/article/911087410-alpha-pro-tech-ltd-announces-first-quarter-2026-financial-results Healthcare Journal of Oregon en PressRelease 2026-05-07T13:00:00+00:00 Alpha Pro Tech, Ltd. Announces First Quarter 2026 Financial Results https://ml.globenewswire.com/media/e9960b3f-da34-42c0-ab32-d247bd68473a/small/logo-jpg.jpg https://www.healthcarejournaloregon.com/article/911087516-marius-pharmaceuticals-announces-key-leadership-expansion-and-launch-of-marius-ai-positioning-the-company-as-the-first-ai-native-pharmaceutical Healthcare Journal of Oregon en PressRelease 2026-05-07T13:00:00+00:00 Marius Pharmaceuticals Announces Key Leadership Expansion and Launch of Marius AI, Positioning the Company as the First AI-Native Pharmaceutical Company https://ml.globenewswire.com/media/0a0cee04-abf8-4e73-bc2b-beede3c3f9d8/small/marius-logo-cmyk-no-background-png.png https://www.healthcarejournaloregon.com/article/911087557-ct-united-fc-partners-with-yale-new-haven-health-to-power-player-performance-and-care Healthcare Journal of Oregon en PressRelease 2026-05-07T13:00:00+00:00 CT United FC Partners with Yale New Haven Health to Power Player Performance and Care https://ml.globenewswire.com/media/YzM4MzNlYjUtYzVjOS00ZWUyLWE2ZjMtODg2NzIyMjAzNjBmLTEzMjAyMjctMjAyNi0wNS0wNy1lbg==/tiny/Connecticut-Sports-Group.png https://www.healthcarejournaloregon.com/article/911087700-kala-bio-announces-reverse-stock-split Healthcare Journal of Oregon en PressRelease 2026-05-07T13:00:00+00:00 KALA BIO Announces Reverse Stock Split https://ml.globenewswire.com/media/15db4366-93ba-40fa-b80d-58cbdde3496e/small/kala-bio-logo-jpg.jpg https://www.healthcarejournaloregon.com/article/911087718-marlyn-expands-solid-dose-cdmo-capabilities-with-a-mechanistic-integrity-driven-manufacturing-platform Healthcare Journal of Oregon en PressRelease 2026-05-07T13:00:00+00:00 Marlyn Expands Solid-Dose CDMO Capabilities with a Mechanistic-Integrity–Driven Manufacturing Platform https://ml.globenewswire.com/media/b86b7a33-5336-4157-a64b-4701c3513cba/medium/advancing-solid-dose-cdmo.png https://www.healthcarejournaloregon.com/article/911088308-biotech-s-next-wave-may-already-be-in-motion Healthcare Journal of Oregon en PressRelease 2026-05-07T12:45:00+00:00 Biotech’s Next Wave May Already be in Motion https://ml.globenewswire.com/media/1f91276c-d820-4666-8efc-2d8786490903/small/neonc-technologies-holding-logo-vector-png.png https://www.healthcarejournaloregon.com/article/911087672-xenon-mri-advances-as-a-cardiopulmonary-biomarker-platform-at-ats-2026 Healthcare Journal of Oregon en PressRelease 2026-05-07T12:44:00+00:00 Xenon MRI Advances as a Cardiopulmonary Biomarker Platform at ATS 2026 https://ml.globenewswire.com/media/442ccb14-d338-4b20-8d17-cb3f0bbc9795/medium/xenon-mri-advances-as-a-cardiopulmonary-biomarker-platform-a.png https://www.healthcarejournaloregon.com/article/911087520-cadrenal-therapeutics-reports-first-quarter-2026-financial-results-and-provides-phase-3-development-update-on-cad-1005-following-end-of-phase-2 Healthcare Journal of Oregon en PressRelease 2026-05-07T12:30:00+00:00 Cadrenal Therapeutics Reports First Quarter 2026 Financial Results and Provides Phase 3 Development Update on CAD-1005 Following End-of-Phase 2 Meeting with FDA https://ml.globenewswire.com/media/dec0fe5d-b262-4ca7-94e0-1fd3856d07a8/small/cvkd-logo-2025-png.png https://www.healthcarejournaloregon.com/article/911087566-dogwood-therapeutics-to-report-first-quarter-2026-financial-results-on-thursday-may-14-2026 Healthcare Journal of Oregon en PressRelease 2026-05-07T12:30:00+00:00 Dogwood Therapeutics to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026 https://ml.globenewswire.com/media/7fe5cc47-6599-477c-a858-0f0d9b9f7eb5/small/green-and-gray-png.png https://www.healthcarejournaloregon.com/article/911087587-health-monitor-network-expands-leadership-position-with-acquisition-of-digital-hcp-marketing-company-d-r-lathian Healthcare Journal of Oregon en PressRelease 2026-05-07T12:30:00+00:00 Health Monitor Network Expands Leadership Position with Acquisition of Digital HCP Marketing Company D+R Lathian https://ml.globenewswire.com/media/ZjNkZTI0OTYtMjQ5Yi00NDY4LWE3OTItYmFiYzcxZmVkYTU4LTEzMDA5MzUtMjAyNi0wNS0wNy1lbg==/tiny/Health-Monitor-Network.png https://www.healthcarejournaloregon.com/article/911088068-milestone-scientific-expands-compuflo-medical-business-with-advisor-program-and-growing-national-clinical-adoption Healthcare Journal of Oregon en PressRelease 2026-05-07T12:30:00+00:00 Milestone Scientific Expands CompuFlo® Medical Business with Advisor Program and Growing National Clinical Adoption https://ml.globenewswire.com/media/408ad3c5-6ad3-41bd-9763-356666216796/small/milestonelogo-rgb-final-jpg.jpg https://www.healthcarejournaloregon.com/article/911088227-quoin-pharmaceuticals-provides-corporate-update-and-reports-first-quarter-2026-financial-results Healthcare Journal of Oregon en PressRelease 2026-05-07T12:30:00+00:00 Quoin Pharmaceuticals Provides Corporate Update and Reports First Quarter 2026 Financial Results https://ml.globenewswire.com/media/7002de7e-dd04-45a5-a382-625d5317dbfd/small/quoin-colored-logo-png-png.png https://www.healthcarejournaloregon.com/article/911088270-oragenics-signs-letter-of-intent-to-license-cardiodialysis-technology-from-sigyn-therapeutics-to-target-tbi-induced-systemic-inflammation Healthcare Journal of Oregon en PressRelease 2026-05-07T12:30:00+00:00 Oragenics Signs Letter of Intent to License CardioDialysis™ Technology from Sigyn Therapeutics to Target TBI-Induced Systemic Inflammation https://ml.globenewswire.com/media/8b2c9d06-f009-4a6e-a465-8a1fe9640993/small/logo-jpg.jpg https://www.healthcarejournaloregon.com/article/911088304-prenetics-im8-named-exclusive-health-supplements-partner-of-inter-miami-cf-in-multi-year-partnership Healthcare Journal of Oregon en PressRelease 2026-05-07T12:30:00+00:00 Prenetics’ IM8 Named Exclusive Health Supplements Partner of Inter Miami CF in Multi-Year Partnership https://ml.globenewswire.com/media/6f6e5613-c1a2-4ad4-829f-7c51b05f6a0a/medium/inter-miami-x-im8.jpg https://www.healthcarejournaloregon.com/article/911088328-ss-innovations-demonstrates-long-distance-telesurgery-capabilities-at-royal-australian-college-of-surgeons-annual-scientific-congress Healthcare Journal of Oregon en PressRelease 2026-05-07T12:30:00+00:00 SS Innovations Demonstrates Long-Distance Telesurgery Capabilities at Royal Australian College of Surgeons Annual Scientific Congress https://ml.globenewswire.com/media/08414f3b-4742-459c-a905-bda30b4cc456/medium/ssi-mantrasana-tele-surgeon-console.png https://www.healthcarejournaloregon.com/article/911088336-cdt-notes-sarborg-filing-of-substance-of-matter-patent-in-cystic-fibrosis-market Healthcare Journal of Oregon en PressRelease 2026-05-07T12:30:00+00:00 CDT Notes Sarborg Filing of Substance of Matter Patent in Cystic Fibrosis Market https://ml.globenewswire.com/media/ZTdlMjI1MTEtYjlhNi00ZDFiLTlmOWYtMzBhNDdmZTRiOGIyLTEyNzQxMDItMjAyNi0wNS0wNy1lbg==/tiny/CDT-Equity-Inc-.png https://www.healthcarejournaloregon.com/article/911088385-instride-health-sustains-outstanding-clinical-results-in-third-annual-outcomes-report-announces-state-expansion-across-east-coast Healthcare Journal of Oregon en PressRelease 2026-05-07T12:30:00+00:00 InStride Health Sustains Outstanding Clinical Results in Third Annual Outcomes Report; Announces State Expansion Across East Coast https://ml.globenewswire.com/media/6f306ebd-faf3-412c-a8c2-b947a12aaa79/small/instride-logo-png.png https://www.healthcarejournaloregon.com/article/911087351-tria-federal-unveils-integrated-solutions-platform-and-new-website Healthcare Journal of Oregon en PressRelease 2026-05-07T12:25:00+00:00 Tria Federal Unveils Integrated Solutions Platform and New Website https://ml.globenewswire.com/media/7fccbdab-446b-4858-9eeb-cc7b137efcc5/medium/tria-federal-website.jpg https://www.healthcarejournaloregon.com/article/911087534-aim-immunotech-announces-50-objective-response-rate-orr-in-upmc-recurrent-ovarian-cancer-phase-2-clinical-trial-suggesting-breakthrough Healthcare Journal of Oregon en PressRelease 2026-05-07T12:23:00+00:00 AIM ImmunoTech Announces 50% Objective Response Rate (ORR) in UPMC Recurrent Ovarian Cancer Phase 2 Clinical Trial, Suggesting Breakthrough Combination Potential https://ml.globenewswire.com/media/4272224c-2335-4a58-9f30-bf722123ab7f/medium/robert-p-edwards-md-mccall-chair-of-obstetrics-gynecology-an.jpg https://www.healthcarejournaloregon.com/article/911088424-theriva-biologics-presenta-los-aspectos-operativos-m-s-destacados-y-los-resultados-financieros-del-primer-trimestre-de-2026 Healthcare Journal of Oregon en PressRelease 2026-05-07T12:13:04+00:00 Theriva™ Biologics presenta los aspectos operativos más destacados y los resultados financieros del primer trimestre de 2026 https://ml.globenewswire.com/media/ed41908b-8799-4f56-bc3c-acff4f4872eb/small/tovx-logo-jpg.jpg https://www.healthcarejournaloregon.com/article/911087444-envue-medical-secures-three-year-purchasing-agreement-renewal-with-the-group-purchasing-organization-gpo-for-one-of-the-largest-health-systems-in Healthcare Journal of Oregon en PressRelease 2026-05-07T12:07:00+00:00 ENvue Medical Secures Three-Year Purchasing Agreement Renewal with the Group Purchasing Organization (GPO) for One of the Largest Health Systems in the U.S. Operating Over 90 Hospitals https://ml.globenewswire.com/media/e0a97028-a7c3-4dd6-a13f-a55e43617883/small/logo-small-722-jpg.jpg https://www.healthcarejournaloregon.com/article/911074025-silo-pharma-files-provisional-patent-for-ibogaine-based-therapeutic-targeting-traumatic-brain-injury Healthcare Journal of Oregon en PressRelease 2026-05-07T12:05:00+00:00 Silo Pharma Files Provisional Patent for Ibogaine-Based Therapeutic Targeting Traumatic Brain Injury https://ml.globenewswire.com/media/3b635464-4382-4b8b-8175-39cc32e08050/small/logo-png.png https://www.healthcarejournaloregon.com/article/911074361-scienture-secures-11-0-million-in-non-dilutive-debt-financing-to-accelerate-growth-of-approved-product-portfolio-and-advancement-of-r-d-pipeline Healthcare Journal of Oregon en PressRelease 2026-05-07T12:05:00+00:00 Scienture Secures $11.0 Million in Non-Dilutive Debt Financing to Accelerate Growth of Approved Product Portfolio and Advancement of R&D Pipeline https://ml.globenewswire.com/media/aeec492f-ff8f-4be3-9000-faf012464b8d/small/logo-png.png https://www.healthcarejournaloregon.com/article/911074473-ardelyx-presents-analysis-supporting-long-term-safety-of-xphozah-at-nkf-s-spring-clinical-meetings Healthcare Journal of Oregon en PressRelease 2026-05-07T12:01:00+00:00 Ardelyx Presents Analysis Supporting Long-Term Safety of XPHOZAH at NKF’s Spring Clinical Meetings https://ml.globenewswire.com/media/cee4ae6d-7a85-44bf-9c02-87e7fa934ec2/small/ardelyx-logo-rgb-jpg.jpg